NCT03707184View on ClinicalTrials.gov

Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 2, 2018

Primary Completion Date

February 3, 2022

Study Completion Date

February 3, 2022

Conditions

Metastatic Prostate CarcinomaProstate Carcinoma Metastatic in the BoneStage IV Prostate Cancer

Interventions

PROCEDURE

Computed Tomography

Undergo PET/CT scan

DRUG

Fluciclovine F18

Given IV

PROCEDURE

Positron Emission Tomography

Undergo PET/CT scan

Trial Locations (1)

84112

Huntsman Cancer Institute/University of Utah, Salt Lake City

All Listed Sponsors

lead

University of Utah

OTHER

NCT03707184 - Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone | Biotech Hunter | Biotech Hunter